Botanical species · safety record

Ipomoea pes-caprae

The EFSA Compendium of Botanicals holds 6 constituent measurements for Ipomoea pes-caprae. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea pes-caprae (L.) R.Br.

6Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Furan derivatives	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Esculetin	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Eugenol	Leaves	Solvent extraction	2.7 Percent	GC-MS	No resolvable identifier
Scopoletin	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Verbenone	Leaves	Solvent extraction	1.01 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Cwalina, Gustav E., Jenkins, Glenn L. A phytochemical study of Ipomea pes-caprae. Journal of the American Pharmaceutical Association, None, p. 585-595.
Marie, D.E.P., Dejan, B., Quetin-Leclercq, J. GC-MS analysis of the leaf essential oil of Ipomea pes-caprae, a traditional herbal medicine in Mauritius. Natural Product Communications, 2007, vol. 2, no. 12, p. 1225-1228.
Wang, Qingji., Wang, Youshao., He, Lei., Zhang, Si. Study on the chemical constituents of Ipomoea pes-caprae (L.) Sweet. Zhongguo haiyang yaowu, 2006, p. 15-17.
PONGPRAYOON, U., BOHLIN, L., BAECKSTROM, P., JACOBSSON, U., LINDSTROM, M. INHIBITION OF ETHYL PHENYLPROPIOLATE-INDUCED RAT EAR EDEMA BY COMPOUNDS ISOLATED FROM IPOMOEA-PES-CAPRAE (L) R BR. PHYTOTHERAPY RESEARCH, 1992, vol. 6, no. 2, p. 104-107. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature